Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Back

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 24, 2007
A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicinRuben C Hartkoorn, Saye Khoo, David J Back, et al.
AIDS (London, England)|October 9, 2002
Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamicsMarta Boffito, Isabella Arnaudo, Riccardo Raiteri, et al.
Antiviral Therapy|March 26, 2004
Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expressionJennifer Ford, David Cornforth, Patrick G Hoggard, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2005
In vitro synergy and enhanced murine brain penetration of saquinavir coadministered with mefloquineAndrew Owen, Omar Janneh, Ruben C Hartkoorn, et al.
Chemical Research in Toxicology|February 28, 2014
Abacavir forms novel cross-linking abacavir protein adducts in patientsXiaoli Meng, Alexandre S Lawrenson, Neil G Berry, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 2008
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individualsLaura Dickinson, Marta Boffito, David J Back, et al.
Clinical Pharmacology and Therapeutics|May 14, 2022
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and ComedicationsCatia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2005
Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimensSimon P Jones, Nadeem Qazi, John Morelese, et al.
AIDS (London, England)|December 4, 2002
Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyureaPatrick G Hoggard, Stephen Kewn, Anlie Maherbe, et al.
AIDS Research and Human Retroviruses|August 17, 2004
The relationship between nevirapine plasma concentrations and abnormal liver function testsLisa M Almond, Marta Boffito, Patrick G Hoggard, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 24, 2007
A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicinRuben C Hartkoorn, Saye Khoo, David J Back, et al.
AIDS (London, England)|October 9, 2002
Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamicsMarta Boffito, Isabella Arnaudo, Riccardo Raiteri, et al.
Antiviral Therapy|March 26, 2004
Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expressionJennifer Ford, David Cornforth, Patrick G Hoggard, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2005
In vitro synergy and enhanced murine brain penetration of saquinavir coadministered with mefloquineAndrew Owen, Omar Janneh, Ruben C Hartkoorn, et al.
Chemical Research in Toxicology|February 28, 2014
Abacavir forms novel cross-linking abacavir protein adducts in patientsXiaoli Meng, Alexandre S Lawrenson, Neil G Berry, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 2008
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individualsLaura Dickinson, Marta Boffito, David J Back, et al.
Clinical Pharmacology and Therapeutics|May 14, 2022
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and ComedicationsCatia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2005
Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimensSimon P Jones, Nadeem Qazi, John Morelese, et al.
AIDS (London, England)|December 4, 2002
Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyureaPatrick G Hoggard, Stephen Kewn, Anlie Maherbe, et al.
AIDS Research and Human Retroviruses|August 17, 2004
The relationship between nevirapine plasma concentrations and abnormal liver function testsLisa M Almond, Marta Boffito, Patrick G Hoggard, et al.
Pageof 10